First in Man Trial of BI 113608

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Healthy
Interventions
DRUG

BI 113608

Low dose powder for oral solution

DRUG

BI 113608

High dose powder for oral solution

DRUG

BI 113608

Medium dose powder for oral solution

DRUG

BI 113608

Low dose powder for oral solution

DRUG

Placebo

Powder for oral solution

DRUG

BI 113608

Low dose powder for oral solution

DRUG

BI 113608

High dose powder for oral solution

DRUG

BI 113608

High dose powder for oral solution

DRUG

BI 113608

Medium dose powder for oral solution

DRUG

BI 113608

Medium dose powder for oral solution

DRUG

BI 113608

Low dose powder for oral solution

Trial Locations (1)

Unknown

Boehringer Ingelheim Investigational Site, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY